As a Biopharma expert at the forefront of tech and innovation, Ivan Kairatov is revolutionizing how we study the human brain. His work focuses on developing advanced, human-relevant models known as brain microphysiological systems to enhance the safety of chemical and drug testing. In our
A brief but deeply impactful federal government shutdown has thrown crucial healthcare services into disarray, abruptly halting the pandemic-era Medicare telehealth and Hospital-at-Home flexibilities that have become a lifeline for millions of Americans. This funding lapse, triggered by a
The intricate landscape of modern medicine is continuously reshaped by technologies that promise to unravel complex clinical puzzles, none more so than the challenge of managing patients with overlapping, high-stakes diseases. AI-Driven Risk Prediction represents a significant advancement in the
With a deep background in biopharma and a keen eye on the intersection of technology and research, Ivan Kairatov has become a leading voice on innovative public health strategies. Today, he joins us to discuss a unique cause-marketing campaign that transforms the retail experience into a powerful
Today we are speaking with Ivan Kairatov, a biopharma expert with deep insight into the intersection of technology and research in mental healthcare. We will be exploring the UK's ambitious new Mental Health Goals programme, a transformative initiative poised to reshape how we understand and treat
A pivotal study in precision oncology is poised to reshape how clinicians approach cancers driven by specific genetic alterations, offering a detailed roadmap for identifying and treating mutations that have long been underrecognized. Led by Dr. Wei Yang and his team, the research introduces a
